Your browser doesn't support javascript.
loading
The quality of reporting of phase II and III trials for new antipsychotics: a systematic review.
Patel, M X; Collins, S; Hellier, J; Bhatia, G; Murray, R M.
Affiliation
  • Patel MX; Department of Psychosis Studies, Institute of Psychiatry,King's College London,UK.
  • Collins S; Department of Psychosis Studies, Institute of Psychiatry,King's College London,UK.
  • Hellier J; Department of Psychosis Studies, Institute of Psychiatry,King's College London,UK.
  • Bhatia G; Department of Psychosis Studies, Institute of Psychiatry,King's College London,UK.
  • Murray RM; Department of Psychosis Studies, Institute of Psychiatry,King's College London,UK.
Psychol Med ; 45(3): 467-79, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25065545
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Schizophrenia / Antipsychotic Agents / Clinical Trials as Topic Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Psychol Med Year: 2015 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Schizophrenia / Antipsychotic Agents / Clinical Trials as Topic Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Psychol Med Year: 2015 Document type: Article Affiliation country: United kingdom